11.4 Nutrition Support Care Plans, Goals & Therapy Reassessment

11.4 Nutrition Support Care Plans, Goals & Therapy Reassessment

Clinical Core: The care plan is a closed clinical loop: assess, identify the nutrition problem and cause, prescribe a measurable intervention, monitor actual response, and revise the plan. A technically correct formula is not adequate if it lacks goals, delivery verification, ownership, and a reassessment date.

From Assessment to a Testable Plan

Begin with a concise problem statement supported by baseline evidence. Separate the problem from its cause and manifestations. For example: inadequate energy delivery related to repeated procedure holds, evidenced by an average delivered volume of 52% of the prescription over 3 days and continued weight loss. That statement points toward interruption management; simply increasing the ordered rate without examining holds may worsen risk without fixing delivery.

A complete plan records:

1. The indication for EN, PN, or combined therapy and why a safer route is insufficient.
2. Energy, protein, fluid, and micronutrient targets, including the weight and method used.
3. Formula or PN composition, route, access, dose, rate, schedule, and advancement plan.
4. Short- and long-term goals with time frames.
5. Monitoring measures, frequency, responsible clinician, and action thresholds.
6. Education needs, preference, affordability, caregiver capacity, and anticipated disposition.
7. Criteria to modify, hold, transition, or stop therapy.

Short-Term and Long-Term Goals

Goals should be specific, measurable, achievable, relevant, and time-bound. “Improve nutrition” is not measurable.

The time horizon matters. A short-term goal may prioritize safe delivery rather than weight gain. A long-term goal should connect therapy to an outcome meaningful to the patient, such as strength, wound healing, growth, ability to complete treatment, or home independence.

Monitoring Domains

Delivery and Adherence

Calculate actual delivery:

$\text{Delivery adequacy (\%)} = \frac{\text{volume or nutrient actually received}}{\text{prescribed amount}} \times 100$

Review procedure holds, pump history, discarded formula, missed PN time, medication conflicts, access problems, oral intake, and caregiver barriers. A patient can fail a goal because the prescription was not delivered, because it was physiologically intolerable, or because the original estimate was wrong; these require different actions.

Clinical and Access Response

For EN, examine tube position or stoma, patency, aspiration risk, stool and emesis pattern, abdominal findings, hydration, and medication causes of symptoms. For PN, examine the vascular access device, infection or thrombosis signs, infusion accuracy, glucose pattern, fluid status, and compounding or administration problems.

Laboratory and Functional Response

Choose tests that can change management. Electrolytes, glucose, renal function, liver tests, triglycerides, blood count, and selected micronutrients are ordered according to route, stability, disease, and duration. Interpret trends with inflammation, fluid shifts, medications, organ function, and assay limitations. Pair biochemical data with weight trajectory, physical findings, strength or function, wound progress, and patient-reported tolerance.

A Structured Reassessment Sequence

When a target is missed or toxicity appears:

1. Confirm the data. Verify weight conditions, sampling time, pump records, and intake/output accuracy.
2. Confirm access and delivery. Was the prescription received through a functioning route?
3. Compare with the goal and time frame. Identify the magnitude and clinical importance of the gap.
4. Identify the dominant cause. Consider disease progression, fluid change, intolerance, adherence, medication, incorrect requirements, or a transition in goals of care.
5. Modify the relevant component. Adjust rate, volume, composition, route, schedule, fluid, electrolytes, or the goal itself.
6. Define the next check. Record what response is expected, by when, who reviews it, and the threshold for escalation.

Avoid changing several variables at once unless the patient is unstable. A controlled change makes the response interpretable.

Adjunctive Pharmacotherapy

Medications may support—but do not replace—a corrected nutrition plan. Examples include prokinetics for documented gastric dysmotility, pancreatic enzymes for exocrine insufficiency, insulin for PN-associated hyperglycemia, antidiarrheal or antisecretory agents in high-output states, bile-acid binders for selected bile-acid diarrhea, and micronutrient repletion for confirmed or likely deficits.

At each reassessment ask: Is the original indication still present? Is there an objective benefit? Is the dose appropriate for renal and hepatic function? Does the drug interact with the formula or feeding schedule? Are adverse effects creating a new nutrition problem? What is the stop or de-escalation criterion? For example, a prokinetic continued without benefit can cause harm; insulin requirements may fall abruptly when cyclic PN stops.

Transition and Discontinuation

Transition is a monitored process, not a single order. Verify that the receiving route is safe and consistently meets the agreed energy, protein, fluid, and medication needs. Account for absorption, not just intake. Reduce the supplemental route in steps when appropriate, monitor hydration and glucose, and avoid gaps caused by supplier or setting changes.

Patient and caregiver education uses teach-back and demonstration. The learner should explain the purpose of therapy, identify warning signs, perform required skills, and know whom to contact. Document the final prescription, monitoring schedule, pending results, responsible clinician, supply plan, and criteria to restart or escalate support.